date:Jul 09, 2014
hin the pharmaceutical industry for several years. This alliance makes it possible to further bridge the gap between the pharmaceutical, food and cosmetics industries, said Dr. Lutz Mller-Kuhrt, CEO of AnalytiCon. Through this new alliance with its long-standing partner BRAIN, the company will be strengthened further but will continue to operate independently on the market.
The synergy between the disciplines of biotechnology and natural product chemistry established in the alliance brings the